Neira Puizina-Ivić

Prof. Dr. Neira Puizina-Ivić


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010
Verified
Journal Article
Closed access
NPNeira Puizina-Ivić
Neira Puizina-Ivić
LMLina Miric
Lina Miric
ACAntoanela Carija
Antoanela Carija
DKDobrila Karlica
Dobrila Karlica
DMDujomir Marasovic
Dujomir Marasovic

27 November 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
DVDubravka Vuković
Dubravka Vuković
MOMarin Ogorevc
Marin Ogorevc
ITIvo Tripković
Ivo Tripković
NPNeira Puizina-Ivić
Neira Puizina-Ivić
MSMirna Saraga-Babić
Mirna Saraga-Babić
SMSnježana Mardešić
Snježana Mardešić
Lichen sclerosus (LS) is a progressive skin disease that is characterized by chronic inflammation of either genital or extragenital skin, and it disproportionately affects women. We analyzed the distribution of nerve fibers, vanilloid receptors, cell proliferation, mast cells and macrophages in genital and extragenital LS samples, as well as in healthy skin, by using immunohistochemistry. The total amount of intraepidermal nerve fibers was lower in LS samples compared to healthy controls, while the total amount of subepidermal nerve fibers and calcitonin gene-related peptide (CGRP) positive fibers was higher in genital LS samples compared to both extragenital LS and healthy controls. Cell proliferation, macrophage and mast cell density were increased in LS samples compared to healthy controls. Genital LS had a higher macrophage density compared to the extragenital variant. Mast cell distribution significantly differed between genital and extragenital LS samples, even though their total mast cell densities were similar. These findings could explain the differences between pruritic symptoms of genital and extragenital LS and provide targets for the research of novel therapeutic strategies for LS management.

13 February 2025 in Medicina
Verified
Journal Article
Open access
PDF file
SKSilvana Karabatić Knezović
Silvana Karabatić Knezović
DKDora Knezović
Dora Knezović
Jelena BanJelena Ban
Jelena Ban
AMAntonela Matana
Antonela Matana
NPNeira Puizina-Ivić
Neira Puizina-Ivić
IHIrena Drmić Hofman
Irena Drmić Hofman
Background and Objectives: This study explores the immunological landscapes of non-melanoma skin neoplasms (NMSNs), specifically keratoacanthoma (KA), squamous cell carcinoma (SCC), and common warts (VV). Although benign, KA shares histological similarities with low-grade SCC. The tumor microenvironment (TME) plays a key role in tumor progression, affecting angiogenesis, inflammation, and immune evasion. Viral infections, particularly human papillomavirus (HPV), are linked to NMSN development, with various HPV types identified in KA. VV, caused by HPV, serves as a comparative model due to its similar etiopathogenesis. Materials and Methods: This research examines the expression of CTLA4, a critical regulator of T-cell homeostasis, and IFN-γ, a cytokine with immunomodulatory and antiviral effects, in the TME of 41 KA, 37 SCC, and 55 VV samples using multichannel immunofluorescence. Results: The analysis revealed distinct patterns of CTLA4 and IFN-γ expression. SCC exhibited a higher prevalence of CTLA4+IFN-γ+ double-positive lymphocytes, suggesting a more immunosuppressive TME. In contrast, VV showed the highest expression of CTLA4+ cells, while both KA and VV had lower expressions of IFN-γ+ lymphocytes compared to SCC. The increased presence of CTLA4+IFN-γ+ double-positive lymphocytes in SCC suggests that the co-expression of these markers may exert a stronger effect on TME modulation than CTLA4 alone. Conclusions: These findings underscore the potential of immune profiling as a diagnostic tool to differentiate between benign and malignant lesions, such as KA and SCC. Furthermore, the presence of CTLA4+IFN-γ+ lymphocytes, particularly in SCC, may serve as a biomarker for tumor progression and a potential target for future immunotherapy strategies aimed at modulating the immune response in NMSN.